A nationwide Chilean cohort study of more than 3.6 million adults found that severe COVID-19 requiring hospitalization was associated with more than an eightfold higher hazard of incident tuberculosis within one year. The association was strongest in the first six months and among unvaccinated individuals, although absolute TB incidence remained low.
While ibuprofen reduced inflammatory markers in drug-resistant TB patients, it did not enhance treatment outcomes, indicating the need for further research.
A protein that acts as a 'control switch,' preventing Mycobacterium tuberculosis from accessing the energy sources it needs to survive, has been identified by researchers at the University of Surrey.
An early view of the immune response to bacteria in the lungs provides clues as to why some people keep TB in check, while others develop disease, suggesting new ways to intervene earlier and stop TB.
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) is the world's deadliest single-agent caused infection, responsible for 1.23 million deaths in 2024, according to the World Health Organization.
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
